Search

everythinglearnresearchcommunity

for

Search:↓

Five-alpha reductase inhibitors, like finasteride and dutasteride, can treat enlarged prostates, improve urination, reduce need for prostate surgery, and lower the risk of prostate cancer, but may increase the risk of higher grade prostate cancer. They can also treat male pattern baldness.

The CDC reports 23 measles cases in unvaccinated US kids, new treatments for eosinophilic esophagitis and osteopenia are approved, poor sleep may cause migraines, atopic dermatitis could lead to asthma, migraines might increase Crohn's disease risk, cancer may raise heart disease risk, gout is linked to prostate issues, Cabo Verde is malaria-free, social factors and vitamin D affect dementia risk, smoking increases hair loss risk, certain drugs might lower thyroid disease risk in arthritis, noma is a neglected disease, and meal timing could impact heart health.

Dutasteride reduces prostate cancer risk by 23% in high-risk men.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

SLCO genes may predict prostate cancer mortality risk, and lifestyle changes improve health in advanced prostate cancer.

5α-reductase inhibitors lower overall prostate cancer risk but not high-grade cancer risk; longer-term screening and new treatments show promise.

Oophorectomy reduces ovarian cancer risk for women with BRCA mutations, finasteride lowers prostate cancer risk without raising death risk, and prophylactic mastectomy rates are rising.

Medications for BPH can have significant side effects, so understanding these risks is important for treatment decisions.

Men's age, urinary symptoms, and heart health risks create different types of erectile dysfunction.

Selenium supplements do not prevent cancer and may have harmful effects.

5 alpha reductase inhibitors can cause sexual, cognitive, and muscle side effects, and may slightly increase aggressive cancer risk.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

Swedish men with the E213 A-allele of the androgen receptor have a lower risk of prostate cancer.

E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.

Gene variant linked to prostate cancer, hormone levels, and hair loss.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

Men who experienced baldness at age 20 may have double the risk of getting prostate cancer.

Men with a certain baldness pattern at age 40-50 may have a higher risk of aggressive prostate cancer.

Dutasteride and finasteride have similar effects on prostate cancer risk in BPH patients.

Taking both finasteride and dutasteride for prostate issues may raise the risk of heart problems.

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Physical activity, height, and smoking affect prostate cancer risk.

Serum triglyceride levels are not linked to prostate cancer risk.

Finasteride is safe for long-term use in prostate cancer treatment.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

Finasteride can't be recommended for cancer prevention due to concerns about high-grade cancer risk.

Hormonal contraceptives and related compounds can increase health risks like thrombosis and affect sexual function.

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.